Ebola virus – proposal for personal protective equipment

Ebola virus – proposal for personal protective equipment

syyskuuta 10 2014

The recent outbreak of the Ebola virus in several West African countries, which has escalated with an increasing number of suspected, probable and confirmed cases, is now starting to cause concern globally. Naturally this has implications for the wider healthcare and medical community, and has given rise to many questions.

What we do know about Ebola is that human-to-human virus transmission occurs from direct contact through broken skin or mucous membranes with the blood or other bodily fluids or secretions (stool, urine, saliva, semen) of infected people. Given the methods of transmission, general guidelines from organisations, such as the World Health Organisation and Centres for Disease Control, have emphasised infection prevention and control measures that healthcare facilities and professionals engage in already. Beyond that, the WHO has issued written guidelines1 that include recommendations for personal protection equipment when caring for patients infected with (or suspected to be infected with) the Ebola virus. These guidelines should be referred to first and foremost.

While Mölnlycke Health Care has not tested its products specifically for use in protection in treating patients infected with Ebola, we do offer products that are designed to fulfil infection control and barrier protection purposes, such as surgical gloves, gowns, face masks and so forth. Our range of products made from impermeable or fluid-repellant material, which protect against microorganism transfer, body fluids and particles and their ordering codes are listed below. For more detailed information on products fulfilling these needs please contact your local Mölnlycke Health Care representative.

More information and references:

  1. WHO, Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola: http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf?ua=1
  2. WHO, Frequently answered questions regarding Ebola: http://www.who.int/csr/disease/ebola/faq-ebola/en/
  3. Centers of Disease Control (CDC), US: http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html
  4. Department of Health, HSE and Advisory committee on dangerous pathogens, UK:https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/343185/ACDP_VHF_guidance_12_08_20141.pdf
  5. The National Board of Health and Welfare (Socialstyrelsen, Sweden): http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19458/2014-6-7.pdf
  6. Pathogen safety data sheet- infectious substances, Public Health Agency of Canada Canada:http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/ebola-eng.php